Table 4.
Age at ESRD Onset | ||||
---|---|---|---|---|
18-39 years | 40-59 years | #x2265; 60 years | p interaction* | |
Race | ||||
White | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | |
African American | 1.67 (1.44-1.93) | 1.26 (1.12-1.41) | 1.01 (0.86-1.20) | <0.0001 |
Asian | 0.99 (0.76-1.29) | 0.68 (0.52-0.90) | 0.37 (0.21-0.65) | 0.03 |
Native American | 1.50 (0.97-2.32) | 1.05 (0.66-1.66) | 0.73 (0.27-1.95) | 0.04 |
Ethnicity | ||||
Non-Hispanic | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | |
Hispanic | 0.94 (0.79-1.12) | 0.78 (0.65-0.94) | 0.76 (0.60-0.98) | 0.36 |
Race/Ethnicity | ||||
Non-Hispanic African Americans | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | |
Hispanic African Americans | 0.99 (0.59-1.63) | 1.06 (0.60-1.88) | 1.45 (0.65-3.22) | 0.11 |
Non-Hispanic Whites | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | |
Hispanic Whites | 0.86 (0.69-1.07) | 0.75 (0.61-0.92) | 0.69 (0.52-0.91) | 0.21 |
Models adjusted for sex, age at ESRD onset, calendar year, type of medical insurance prior to ESRD, body mass index, estimated glomerular filtration rate, albumin, employment status, area-level socioeconomic status, U. S. region of residence, type of renal replacement therapy and comorbidities (smoking, hypertension, diabetes mellitus, coronary artery disease, heart failure, cerebrovascular accidents, chronic obstructive pulmonary disease, peripheral vascular disease and cancer).
p interaction= multiplicative interaction from a model additionally including interaction terms for race and each age category.